| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |